Abcellera Biologics 

Yahoo Finance • 3 months ago

Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks

In this article, we will take a detailed look at Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks. For a quick overview of such stocks, read our article Billionaire Investor Stan Druckenmiller and Inside... Full story

Yahoo Finance • 4 months ago

AbCellera Announces Resignation of Board Member

VANCOUVER, British Columbia, February 23, 2024--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that Peter Thiel has notified the Company of his intention to resign from the Company’s Board of Directors for personal reasons, effe... Full story

Yahoo Finance • 7 months ago

16 Best Penny Stocks To Buy For 2024

In this article, we will take a detailed look at the16 Best Penny Stocks To Buy For 2024. For a quick overview of such stocks, read our article 5 Best Penny Stocks To Buy For 2024. The stock market’s optimism wave recently saw a break aft... Full story

Yahoo Finance • 8 months ago

AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023

New data from AbCellera’s T-cell engager platform demonstrates that diverse CD3-binding antibodies enable optimization of T-cell engager function beyond what is possible by modifying a single CD3-binder VANCOUVER, British Columbia, Novemb... Full story

Yahoo Finance • 8 months ago

AbCellera Reports Q3 2023 Business Results

Total revenue of $7 million, compared to $101 million in Q3 2022 Total cumulative partnered program starts of 110, up 20% from Q3 2022 Net loss of $0.10 per share on a basic and diluted basis, compared to net earnings of $0.09 and $0.08 pe... Full story

Yahoo Finance • 8 months ago

Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology

WILMINGTON, Del. & VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (“Prelude”) (Nasdaq: PRLD) and AbCellera (Nasdaq: ABCL) today announced a multi-year, multi-program partnership to discov... Full story

Yahoo Finance • 10 months ago

11 Cheap Small-Cap Stocks to Buy Before the Next Breakout

In this piece, we will take a look at 11 cheap small cap stocks to buy before the next breakout. If you want to skip out on an introduction to small cap stocks and the latest events in the stock market, then take a look at 5 Cheap Small-Ca... Full story

Yahoo Finance • 10 months ago

Billionaire Stan Druckenmiller’s Small-Cap Stock Picks

In this piece, we will take a look at billionaire Stanley Druckenmiller's small-cap stock picks. If you want to skip our introduction to Mr. Druckenmiller and small-cap stocks in general, then head on over to Billionaire Stan Druckenmiller... Full story

Yahoo Finance • last year

AbCellera Biologics Inc.'s (NASDAQ:ABCL) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

It is hard to get excited after looking at AbCellera Biologics' (NASDAQ:ABCL) recent performance, when its stock has declined 19% over the past month. However, a closer look at its sound financials might cause you to think again. Given tha... Full story

Yahoo Finance • 2 years ago

AbCellera’s First Program with Regeneron in Multi-Target Collaboration Advances in Preclinical Development

VANCOUVER, British Columbia, November 02, 2022--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) announced today that Regeneron has elected to exercise its right to advance a therapeutic antibody candidate, discovered in partnership with AbCeller... Full story

Yahoo Finance • 2 years ago

12 Best Stocks Under $50

In this article, we will look at the 12 best stocks to buy under $50. If you want to explore similar stocks, you can also take a look at 5 Best Stocks Under $50. Stocks have been sandwiched between inflation and an aggressive Fed. Equity... Full story